Show items per page
Elements: 17
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Pharmacological treatment options for low Bone Mineral Density and secondary osteoporosis in Anorexia Nervosa: A systematic review of the literature Robinson, Lauren; Aldridge, Victoria; Clark, Emma M; Misra, Madhusmita; Micali, Nadia 2017
add to browser selection
Contraception chez les adolescentes et santé osseuse Julen, Olivier Gregory; Larigaldie, Sophie; Yaron, Michal 2012
add to browser selection
Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study Rizzoli, René; Chapurlat, R D; Laroche, J-M; Krieg, M A; ... Felsenberg, D 2012
add to browser selection
Inhibiteurs sélectifs de la recapture de la sérotonine (ISRS) et ostéoporose Fétique-Will, Anne-Catherine; Chevalley, Thierry; Rizzoli, René 2011
add to browser selection
Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL Pierroz, Dominique D.; Bonnet, Nicolas; Baldock, Paul A.; Ominsky, Michael S.; ... Ferrari, Serge Livio 2010
add to browser selection
Denosumab Rizzoli, René; Yasothan, Uma; Kirkpatrick, Peter 2010
add to browser selection
Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis Rizzoli, René; Laroche, Michel; Krieg, Marc-Antoine; Frieling, Isolde; ... Felsenberg, Dieter 2010
add to browser selection
Bone fractures after menopause ESHRE Capri Workshop Group. 2010
add to browser selection
Continuous broad protection against osteoporotic fractures with strontium ranelate Ferrari, Serge Livio 2009
add to browser selection
Androgen replacement therapy improves function in male rat muscles independently of hypertrophy and activation of the Akt/mTOR pathway Hourde, C.; Jagerschmidt, C.; Clement-Lacroix, P.; Vignaud, A.; ... Ferry, A. 2009
add to browser selection
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science Compston, J.; Reid, D M.; Boisdron, J.; Brandi, M-L.; ... Reginster, J-Y. 2008
add to browser selection
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel Aapro, M.; Abrahamsson, P. A.; Body, J. J.; Coleman, R. E.; ... Thurlimann, B. 2008
add to browser selection
Post-fracture management of patients with hip fracture: a perspective Bruyere, O.; Brandi, M-L; Burlet, N.; Harvey, N.; ... Akesson, K. 2008
add to browser selection
Prevention of trabecular bone loss induced by estrogen deficiency by a selective p38alpha inhibitor Caverzasio, Joseph; Higgins, Linda; Ammann, Patrick 2008
add to browser selection
Pamidronate and osteoporosis prevention in liver transplant recipients Pennisi, Pietra; Trombetti, Andrea; Giostra, Emiliano; Mentha, Gilles; ... Fiore, Carmelo 2007
add to browser selection
Long-term effect of early vitamin-D supplementation on bone mineral status in prematurely born infants Zamora, Samuel Antonio; Rizzoli, René; Belli, Dominique Charles 2000
add to browser selection
Bone mineral density in lung-transplant recipients before and after graft: prevention of lumbar spine post-transplantation-accelerated bone loss by pamidronate Trombetti, Andrea; Gerbase, Margaret; Spiliopoulos, Anastase; Slosman, Daniel; ... Rizzoli, René 2000